Description
Kimyrsa is an intravenous antibiotic containing oritavancin diphosphate, a lipoglycopeptide used to treat certain bacterial infections like skin and soft tissue infections. It comes as a lyophilized powder that is mixed into a solution for injection. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Oritavancin diphosphate | HTML | Access the FDA dataset for Oritavancin diphosphate — ANDA 214155 submitted by Mylan Institutional LLC | Open resource |